Hans Grünwald

2.0k total citations
52 papers, 1.4k citations indexed

About

Hans Grünwald is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Hans Grünwald has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 23 papers in Public Health, Environmental and Occupational Health and 19 papers in Genetics. Recurrent topics in Hans Grünwald's work include Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Hans Grünwald is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Hans Grünwald collaborates with scholars based in United States, Canada and Belgium. Hans Grünwald's co-authors include Fred Rosner, Jack Goldberg, George P. Browman, Richard A. Larson, Harvey D. Preisler, Azra Raza, Ralph Vogler, N. Azarnia, John M. Bennett and Mahboobeh Zarrabi and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Hans Grünwald

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Grünwald United States 21 789 408 403 365 338 52 1.4k
George Omura United States 18 1.0k 1.3× 510 1.3× 619 1.5× 532 1.5× 240 0.7× 52 2.5k
E Jacky Switzerland 15 882 1.1× 370 0.9× 314 0.8× 287 0.8× 173 0.5× 25 1.3k
Jyh-Pyng Gau Taiwan 16 1.0k 1.3× 299 0.7× 415 1.0× 562 1.5× 295 0.9× 62 1.7k
Oumédaly Reman France 20 635 0.8× 199 0.5× 385 1.0× 327 0.9× 236 0.7× 61 1.4k
H Rubie France 28 397 0.5× 278 0.7× 649 1.6× 537 1.5× 270 0.8× 75 2.3k
Bitran Jd United States 14 596 0.8× 247 0.6× 431 1.1× 272 0.7× 135 0.4× 33 1.2k
G. Solbu Netherlands 21 1.3k 1.7× 779 1.9× 707 1.8× 613 1.7× 382 1.1× 51 2.1k
R A Clift United States 14 1.2k 1.5× 292 0.7× 596 1.5× 145 0.4× 183 0.5× 18 1.7k
Canellos Gp United States 20 516 0.7× 179 0.4× 361 0.9× 116 0.3× 412 1.2× 49 1.3k
Piera Viero Italy 24 1.2k 1.6× 498 1.2× 675 1.7× 336 0.9× 737 2.2× 81 2.3k

Countries citing papers authored by Hans Grünwald

Since Specialization
Citations

This map shows the geographic impact of Hans Grünwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Grünwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Grünwald more than expected).

Fields of papers citing papers by Hans Grünwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Grünwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Grünwald. The network helps show where Hans Grünwald may publish in the future.

Co-authorship network of co-authors of Hans Grünwald

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Grünwald. A scholar is included among the top collaborators of Hans Grünwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Grünwald. Hans Grünwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peppercorn, Jeffrey, Iuliana Shapira, Deborah Collyar, et al.. (2010). Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology. Journal of Clinical Oncology. 28(15). 2635–2640. 60 indexed citations
2.
Grünwald, Hans. (2007). Ethical and Design Issues of Phase I Clinical Trials in Cancer Patients. Cancer Investigation. 25(2). 124–126. 9 indexed citations
3.
Shanske, Alan, Hans Grünwald, Perry Cook, Nora Heisterkamp, & John Groffen. (1998). Philadelphia-negative chronic myelogenous leukemia in a patient with a unique complex translocation: 46,XY,t(9;12;15)(q34;q12;q21). Leukemia Research. 22(7). 645–648. 1 indexed citations
4.
Rosner, Fred & Hans Grünwald. (1997). The patient with anemia. 2(6). 177–180. 2 indexed citations
5.
Shanske, Alan, et al.. (1996). A myeloproliferative disorder with eosinophilia associated with a unique translocation (3;5). British Journal of Haematology. 95(3). 524–526. 11 indexed citations
6.
Rosner, Fred & Hans Grünwald. (1996). Folic Acid Food Supplementation: An Idea Whose Time Has Not Come. Journal of women's health. 5(5). 427–428. 1 indexed citations
7.
Raza, Azra, Harvey D. Preisler, Beatrice C. Lampkin, et al.. (1993). Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia. American Journal of Hematology. 42(2). 147–157. 13 indexed citations
8.
Goldberg, Jack, Azra Raza, John M. Bennett, et al.. (1993). Mitoxantrone and 5‐azacytidine for refractory/relapsed ANLL or CML in blast crisis: A leukemia intergroup study. American Journal of Hematology. 43(4). 286–290. 19 indexed citations
9.
Raza, Azra, Harvey D. Preisler, Richard A. Larson, et al.. (1993). Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia. American Journal of Hematology. 42(4). 359–366. 11 indexed citations
10.
Larson, Richard A., Roger Day, N. Azarnia, et al.. (1992). The selective use of AMSA following high‐dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study. British Journal of Haematology. 82(2). 337–346. 13 indexed citations
11.
Grünwald, Hans, et al.. (1991). Use of Vincristine in Refractory Thrombotic Thrombocytopenic Purpura. Acta Haematologica. 85(1). 37–40. 27 indexed citations
12.
Larson, Richard A., Azra Raza, George P. Browman, et al.. (1991). The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure. British Journal of Haematology. 79(3). 390–397. 21 indexed citations
13.
Khan, Shakila P., Azra Raza, Maurice Barcos, et al.. (1991). Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. Leukemia Research. 15(1). 51–57. 3 indexed citations
14.
Sato, Hiroshi, Harvey D. Preisler, Roger Day, et al.. (1990). MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. British Journal of Haematology. 75(3). 340–345. 157 indexed citations
15.
Lamm, Steven H., et al.. (1989). Consistencies and inconsistencies underlying the quantitative assessment of leukemia risk from benzene exposure.. Environmental Health Perspectives. 82. 289–297. 29 indexed citations
16.
Raza, Azra, Yogesh Maheshwari, Zahida Yasin, et al.. (1987). Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia.. PubMed. 14(2 Suppl 1). 217–25. 14 indexed citations
17.
Gessner, Teresa, HD Preisler, N. Azarnia, et al.. (1987). Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy. Medical Oncology and Tumor Pharmacotherapy. 4(1). 23–31. 10 indexed citations
18.
Rosner, Fred & Hans Grünwald. (1984). Association of T cell acute lymphoblastic leukemia and histiocytic medullary reticulosis. The American Journal of Medicine. 77(5). 910–914. 11 indexed citations
19.
Rosner, Fred, Hans Grünwald, & Mahboobeh Zarrabi. (1979). Acute leukemia as a complication of cytotoxic chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 5(9). 1705–1707. 5 indexed citations
20.
Jipp, P., et al.. (1971). [Glucose tolerance and arteriosclerosis].. PubMed. 66(50). 1738–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Omura Breakdown of academic impact, for papers by E Jacky Breakdown of academic impact, for papers by Jyh-Pyng Gau Breakdown of academic impact, for papers by Oumédaly Reman Breakdown of academic impact, for papers by H Rubie Breakdown of academic impact, for papers by Bitran Jd Breakdown of academic impact, for papers by G. Solbu Breakdown of academic impact, for papers by R A Clift Breakdown of academic impact, for papers by Canellos Gp Breakdown of academic impact, for papers by Piera Viero
Rankless by CCL
2026